BIOMAT Database Logo BIOMAT Database Logo

[Clinical study on tuberactinomycin-N, a new antibiotic]. 1972

T Osato, and M Toyoara

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D013302 Streptomyces A genus of bacteria that form a nonfragmented aerial mycelium. Many species have been identified with some being pathogenic. This genus is responsible for producing a majority of the ANTI-BACTERIAL AGENTS of practical value.
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

T Osato, and M Toyoara
[Clinical study of a new antibiotic, tuberactinomycin-N, in pulmonary tuberculosis].
January 1973, Kekkaku : [Tuberculosis],
T Osato, and M Toyoara
Studies on tuberactinomycin. II. Isolation and properties of tuberactinomycin-N, a new tuberactinomycin group antibiotic.
October 1971, The Journal of antibiotics,
T Osato, and M Toyoara
Experimental and clinical study on the antituberculous activity of tuberactinomycin-N, a new antibiotic.
August 1974, Bulletin of the International Union against Tuberculosis,
T Osato, and M Toyoara
Chemical studies on tuberactinomycin. XVI. Synthesis of tuberactinomycin N.
October 1979, The Journal of antibiotics,
T Osato, and M Toyoara
[Clinical study of tuberactinomycin-N in pulmonary tuberculosis (author's transl)].
October 1973, Kekkaku : [Tuberculosis],
T Osato, and M Toyoara
Chemical studies on tuberactinomycin. VIII. Isolation of tuberactinamine N, the cyclic peptide moiety of tuberactinomycin N, and conversion of tuberactinomycin N to O.
April 1975, The Journal of antibiotics,
T Osato, and M Toyoara
[Clinical study on tuberactinomycin-N (TUM-N) and viomycin (VM) in retreatment of pulmonary tuberculosis (author's transl)].
July 1974, Kekkaku : [Tuberculosis],
T Osato, and M Toyoara
Chemical studies on tuberactinomycin. XIII. Modification of beta-ureidodehydroalanine residue in tuberactinomycin N.
November 1977, The Journal of antibiotics,
T Osato, and M Toyoara
Study on the antituberculous activity of tuberactinomycin, a new antimicrobial drug.
August 1969, The American review of respiratory disease,
T Osato, and M Toyoara
Studies on tuberactinomycin (tuberactin), a new antibiotic. I. Taxonomy of producing strain, isolation and characterization.
December 1968, The Journal of antibiotics,
Copied contents to your clipboard!